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Introduction and Objectives 
Venous thromboembolism, risk of which is increased in surgical patients, is a 
preventable cause of morbidity and death. The primary objective of this study was to 
estimate the incidence of symptomatic postoperative venous thromboembolism in adults 
at a tertiary university hospital, overall and by surgical specialty. The secondary 
objective was to analyze severity of and mortality from thromboembolic events. 
Methods 
We performed a retrospective study to identify cases of in-hospital postoperative venous 
thromboembolism, encoded by the International Classification of Diseases, Ninth 
Revision, according to the Joint Commission International criteria. Adult patients 
admitted for surgery in 2008-2012 were included. 
Results 
Among 67635 hospitalizations, 90 cases of postoperative symptomatic venous 
thromboembolism were identified (median age 59 years), corresponding to an incidence 
of 1.33/1000 admissions (95% confidence interval [CI] 1.1-1.6/1000). Neurosurgery 
had the highest risk (4.07/1000), followed by urological surgery and general surgery 
(p<0.001). There were 50 cases of pulmonary embolism, 11 of which were fatal. Of the 
90 cases, 12.2% occurred under neuraxial anesthesia and 55.1% in patients with 
American Society of Anesthesiology III physical status. At least 37.7% of patients with 
events received a prophylactic dose of injectable anticoagulant postoperatively. The 
overall risk decreased from 2008 to 2012. Venous thromboembolism-associated 
mortality during hospitalization was 21.1% (95% CI 13.6-30.4). 
Conclusions 
The incidence of postoperative symptomatic venous thromboembolism was 1.33/1000. 
Neurosurgery showed the greatest risk. Mortality was 21.1%. 
Keywords: Complication; Complicação; Especialidades cirúrgicas; Incidence; 
Incidência; Patient safety; Risco; Risk; Segurança do doente; Surgical specialties; 
Thromboembolism, venous; Tromboembolismo venoso 
Introdução e objetivos 
O tromboembolismo venoso, cujo risco está aumentado no doente cirúrgico, é uma 
causa evitável de morbimortalidade. O objetivo primário deste estudo foi estimar o risco 
de tromboembolismo venoso sintomático pós-operatório global e por especialidade 
cirúrgica, num hospital terciário. Secundariamente, foram analisadas a gravidade e 
mortalidade dos eventos tromboembólicos. 
Métodos 
Foi realizado um estudo retrospetivo para a identificação de casos de tromboembolismo 
venoso pós-operatório intra-hospitalar, codificados pela Classificação Internacional de 
Doenças – 9.ª revisão, pelos critérios da Joint Commission International. Foram 
incluídos episódios de internamento de doentes adultos, operados, no período 2008-
2012. 
Resultados 
Em 67635 episódios de internamento com cirurgia identificaram-se 90 casos de 
tromboembolismo venoso pós-operatório (mediana de idades: 59 anos), correspondendo 
a um risco de 1,33/1000 episódios (intervalo de confiança a 95% [IC95%], 1,1-
1,6/1000). A neurocirurgia apresentou maior risco (4,07/1000), seguida pela urologia e 
pela cirurgia geral p<0,001. Houve 50 episódios de embolia pulmonar, dos quais 11 
foram fatais. Dos 90 casos, 12,2% decorreram sob anestesia do neuro-eixo e 55,1% em 
doentes com estado físico ASA III. Foi administrada dose profilática de anticoagulante 
injetável no pós-operatório a, pelo menos, 37,7% dos doentes. O risco decresceu de 
2008 até 2012. A mortalidade associada aos eventos de tromboembolismo venoso 
durante o internamento foi 21,1% (IC95%, 13,6-30,4). 
Conclusões 
O risco de tromboembolismo venoso sintomático pós-operatório foi de 1,33/1000. A 
neurocirurgia apresentou maior risco. A mortalidade foi de 21,1%. 
 
Introduction 
Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and 
pulmonary embolism (PE), is a leading cause of morbidity and mortality and results in 
high financial costs, and is considered a major public health problem. The estimated 
annual incidence rates of VTE range between 104 and 183/100000 person-years
1
; early 
mortality is 12.6% and five-year mortality is 50-60% for PE and 25% for DVT.
2
 
It is difficult to obtain reliable and comparable estimates of VTE incidence, for various 
reasons. Symptoms and clinical signs are non-specific, and hence only 50% of cases are 
diagnosed and the predictive value of screening asymptomatic patients is low.
3
 These 
factors help explain the variations seen in epidemiological data from different studies, 
although there are also differences related to ethnicity.
1
 
Surgical patients are at increased risk for VTE, which in the absence of 
thromboprophylaxis ranges between 15% and 60% depending on the type of surgery; it 
is highest in major orthopedic procedures.
4,5
 Individual patient characteristics, type of 
anesthesia, and length of procedure and hospital stay also affect risk.
4,5
 
The ENDORSE study,
6
 which analyzed VTE risk in 32 countries, showed that of the 
762 surgical patients assessed in Portugal, 69% were at risk. Despite the importance of 
awareness of outcome indicators, there have been few epidemiological studies on 
postoperative VTE in Portugal. 
Objectives 
The primary objective of the postoperative venous thromboembolism (TREVO) study 
was to estimate the incidence of symptomatic postoperative VTE, overall and by 
surgical specialty, at a tertiary hospital. The secondary objective was to analyze severity 
of and mortality from thromboembolic events, including the characteristics of the 
patients involved and their treatment. 
Methods 
TREVO is a retrospective epidemiological study of an adult population of surgical 
patients at Centro Hospitalar de São João, a tertiary university hospital. The study was 
approved by the institution's ethics committee. 
Study design 
All hospitalizations recorded in the hospital's database of patients aged 18 or over 
admitted for at least one elective or urgent surgical procedure between January 1, 2008 
and December 31, 2012 were analyzed. 
Cases of VTE as a secondary diagnosis during the first 120 days of hospital stay were 
identified based on the codes of the International Classification of Diseases, Ninth 
Revision, Clinical Modification (ICD-9). The criteria used were those of the Joint 
Commission International
7
 (Table 1). 
Table 1. 
Joint Commission International criteria for a diagnosis of venous thromboembolism. 
 
ICD-9 
code  Description  
415.11  Iatrogenic pulmonary embolism and infarction  
415.19  
Other pulmonary embolism and infarction (excludes septic embolism and 
that complicating pregnancy)  
451.11  Phlebitis and thrombophlebitis of femoral vein (deep)  
451.19  Phlebitis and thrombophlebitis of other deep veins of lower extremities  
451.2  Phlebitis and thrombophlebitis of lower extremities, unspecified  
451.81  Phlebitis and thrombophlebitis of iliac vein  
451.9  Phlebitis and thrombophlebitis of unspecified site  
453.40  
Venous embolism and thrombosis of unspecified deep vessels of distal 
lower extremity  
453.41  
Venous embolism and thrombosis of deep vessels of proximal lower 
extremity  
453.87  Acute venous embolism and thrombosis of other thoracic veins  
ICD-9 
code  Description  
453.89  Acute venous embolism and thrombosis of other specified veins  
453.9  Other venous embolism and thrombosis of unspecified site  
ICD-9: International Classification of Diseases, Ninth Revision. 
Medical records, both electronic and paper versions, of the cases identified were 
reviewed. The relevant data were entered on a specially designed form, and included 
demographic characteristics and associated diseases, admission and discharge 
diagnoses, treatment details, including type of anesthesia, type of surgery, central 
venous catheterization, postoperative immobility for more than two days and 
prescription of postoperative thromboprophylactic drugs, and vital status at discharge. 
The severity of postoperative VTE was classified into four groups: fatal PE, non-fatal 
PE, DVT and other VTE. 
Surgical patients who were admitted but not operated, those with incomplete records 
and those in whom a secondary diagnosis of VTE was not confirmed were excluded, as 
were those in whom VTE occurred before surgery. 
The selection of cases was based on a recorded diagnosis of VTE, supported by a report 
of imaging findings. PE was confirmed by spiral computed tomography, digital 
subtraction angiography or high-probability ventilation-perfusion scan; DVT by 
ultrasound or venography; and other VTE by ultrasound, venography or magnetic 
resonance angiography. The images were not reviewed by the investigators, who 
nevertheless checked the information recorded against the ICD-9 code. 
The episodes initially identified were subsequently reviewed by a different investigator 
in order to confirm the data collected. 
The outcome analyzed was symptomatic VTE, since the hospital's policy is to refer 
patients for imaging studies based on clinical assessment rather than to screen for VTE. 
In cases in which there was more than one VTE event, only the most severe was 
considered in the statistical analysis. 
Statistical analysis 
Descriptive statistics were used to analyze the data, expressed as medians and 
interquartile range (P25-P75) for quantitative variables and percentages for qualitative 
variables. Estimates are presented with 95% confidence intervals (CI). The incidence of 
VTE and PE among the subgroups was compared by the chi-square test. Tests for linear 
tendency were used to assess changes over time in the risk for a VTE event. The data 
were analyzed using Stata for Windows, version 11.1 (StataCorp LP, College Station, 
TX) and Microsoft Excel 2010 (Microsoft Corp., Redmond, WA). 
ResultsCase selection 
The study sample consisted of 67635 admissions of adult patients for cardiothoracic, 
general, plastic, vascular, neurological, orthopedic, otorhinolaryngological or urological 
surgery. 
Of the 178 cases initially identified with VTE according to the ICD-9 diagnostic codes, 
35 patients were excluded as they were not operated, 16 due to incomplete data, nine 
due to diagnostic codes inconsistent with the clinical information, and 28 because the 
VTE event occurred before surgery (Figure 1). 
 
Figure 1. 
(0.19MB). 
Identification of cases of venous thromboembolism in the study population. ICD-9: 
International Classification of Diseases, Ninth Revision; VTE: venous 
thromboembolism. 
Demographic characteristics 
The overall incidence of VTE was similar in men and women (1.35 vs. 1.31/1000 
admissions, respectively, p=0.96), but 63.6% of those with fatal PE were female. 
The median age of those with VTE was 59 years (P25-P75: 46-70). There was no 
significant difference in mean age between cases of VTE and the overall study 
population (p=0.191). Fatal PE occurred at a mean age of 63.3±10.6 years. Patients with 
VTE tended to be younger (mean 54±16.3 years). 
Risk by surgical specialty 
The 90 confirmed cases of symptomatic postoperative VTE correspond to an incidence 
of 1.33/1000 admissions (95% CI: 1.1-1.6/1000). Regarding estimated risk by surgical 
specialty, neurosurgery had the highest risk (4.07/1000), followed by urological surgery 
(1.55/1000) and general surgery (1.42/1000) (p<0.001). Plastic surgery had the lowest 
risk (0.47/1000) (Figure 2). 
 
Figure 2. 
(0.07MB). 
Risk of venous thromboembolism, with or without pulmonary embolism, by surgical 
specialty. CT: cardiothoracic; DVT: deep vein thrombosis; Neuro: neurological; ORL: 
otorhinolaryngological; PE: pulmonary embolism; Plastic: reconstructive and 
maxillofacial; VTE: venous thromboembolism. 
Among the neurosurgical cases, PE was observed in five procedures to remove 
neoplastic lesions (two acoustic neuromas, one astrocytoma, one hypophyseal adenoma 
and one meningioma) and in another five procedures (two to drain brain abscess, one 
brain biopsy, one to drain cerebral hemorrhage, and one to implant an intracranial 
pressure monitor). There were three cases of DVT in procedures to drain subdural 
hematomas and one in a procedure to drain an intracerebral hemorrhage. One patient 
with Parkinson's disease undergoing implantation of a deep brain stimulator had another 
type of VTE. None of the patients with neoplastic lesions had fatal PE. 
Of the 14 urological patients, four underwent kidney transplantation and PE occurred in 
three of these and another type of VTE in one. One of the transplant patients presented 
PE, DVT and another type of VTE. This patient and another transplant recipient, both 
male, died. PE was also a complication in a transurethral resection of the prostate, a 
ureteroscopy with biopsy and a nephroureterectomy. All other episodes in urological 
patients were DVT. 
Of the 90 cases of TVE, 11 (12.2%) occurred under neuraxial anesthesia, which in three 
cases was combined with general anesthesia and in two was combined subarachnoid 
and epidural block. 
The distribution of TVE cases according to the American Society of Anesthesiology 
(ASA) classification of physical status was as follows: ASA III (55.1%), ASA II 
(21.4%) and ASA IV (13.5%). 
The overall incidence of TVE fell over the study period, from 1.95/1000 in 2008 to 
1.01/1000 in 2012 (p=0.036 for linear tendency) (Figure 3). 
 
Figure 3. 
(0.05MB). 
Annual changes in overall risk of venous thromboembolism, 2008-2012. VTE: venous 
thromboembolism. 
Severity of events 
Of the total, 50 cases of PE were identified, corresponding to an incidence of 0.75/1000 
episodes (95% CI: 0.56-0.99/1000), highest in neurosurgery (2.39/1000), followed by 
orthopedic (0.91/1000) and urological procedures (0.89/1000) (Figure 2). 
There were 11 fatal PE (22.0% mortality), most frequently associated with neoplastic 
disease or renal failure (Table 2). Over half of these patients had undergone central 
venous catheterization of the right subclavian vein, and 72.7% had a central catheter if 
those with catheterization of the internal jugular are included (Table 3). 
 
Table 2. 
Characteristics of patients according to type of thromboembolic event. 
Characteristics  Fatal PE  
Non-fatal 
PE  DVT  
Other 
VTE  
  (N=11)  (N=39)  (N=33)  (N=7)  
Male/female, n  4/7  22/17  16/17  4/3  
Age (years), mean ± SD  63.3±10.6  58.8±17.2  54.3±16.3  60.1±15.8  
Body mass index >30 kg/m2, 
n  
2/11 (ND 
2)  
9/39 (ND 
8)  
10/33 (ND 
5)  1/7  
Associated acute disease 
Heart failure NYHA III/IV, 
n/N (%)  
2/11 
(18.2)  2/39 (5.1)  0  1/7 (14.3)  
Respiratory failure (COPD or 
pneumonia), n/N (%)  
2/11 
(18.2)  
9/39 
(23.1)  3/33 (9.1)  2/7 (28.6)  
Acute, chronic or terminal 
renal failure, n/N (%)  
3/11 
(27.3)  
7/39 
(17.9)  3/33 (9.1)  5/7 (71.4)  
Associated neoplastic disease, 
n/N (%)  
4/11 
(36.4)  
7/39 
(17.9)  9/33 (27.3)  0  
Sepsis, n/N (%)  
2/11 
(18.2)  
5/39 
(12.8)  6/33 (18.2)  1/7 (14.3)  
COPD: chronic obstructive pulmonary disease; DVT: deep vein thrombosis; n: number 
of cases by characteristic; N: total number of events; ND: no data; NYHA: New York 
Heart Association; PE: pulmonary embolism; SD: standard deviation; VTE: venous 
thromboembolism. 
 
Table 3. 
Characteristics of treatment by type of thromboembolic event. 
Characteristic  Fatal PE  
Non-fatal 
PE  DVT  
Other 
VTE  
  (N=11)  (N=39)  (N=33)  (N=7)  
Type of anesthesia 
General, n/N (%)  
10/11 
(90.9)  
33/39 
(84.6)  
27/33 
(81.8)  
7/7 
(100)  
Neuraxial, n/N (%)  1/11 (9.1)  
5/39 
(12.8)  2/33 (6.1)  0  
General + neuraxial, n/N (%)  0  0  3/33 (9.1)  0  
Other, n/N (%)  0  1/39 (2.6)  1/33 (3.0)  0  
Central venous catheter 
Characteristic  Fatal PE  
Non-fatal 
PE  DVT  
Other 
VTE  
  (N=11)  (N=39)  (N=33)  (N=7)  
Internal jugular, n/N (%)  
2/11 
(18.2)  2/39 (5.1)  
5/33 
(15.2)  
3/7 
(42.8)  
Subclavian, n/N (%)  
6/11 
(54.5)  3/39 (7.7)  3/33 (9.1)  0  
Postoperative immobility >2 days, 
n/N (%)  
7/11 
(63.6)  
9/39 
(23.1)  
15/33 
(45.5)  
3/7 
(42.8)  
Postoperative thromboprophylaxis 
Enoxaparin dose: prophylactic or 
more, n/N (%)  
4/11 
(36.4)  
13/39 
(33.3)  
14/33 
(42.4)  
2/7 
(28.6)  
Enoxaparin dose: less than 
prophylactic, n/N (%)  0  
6/39 
(15.4)  0  0  
Unfractionated heparin  0  1/39 (2.6)  0  0  
Cases with no information 
available  1  6  4  2  
DVT: deep vein thrombosis; n: number of cases by characteristic; N: total number of 
events; PE: pulmonary embolism; VTE: venous thromboembolism. 
Immobility for more than two days was associated with a greater number of severe 
events (Table 3). 
At least 37.7% of patients with events received a prophylactic dose of injectable 
anticoagulant postoperatively (Table 3). 
Nineteen patients with VTE died. Possible causes are shown in Table 4. 
 
Table 4. 
Causes associated with mortality in patients with venous thromboembolism. 
Causes  n  
Cardiogenic shock  1  
Septic shock  1  
PE  11  
Renal infection  1  
Renal failure  1  
Kidney cancer  1  
Pneumonia  1  
Sepsis + multiorgan failure  1  
DVT + IVCS  1  
DVT: deep vein thrombosis; IVCS: inferior vena cava syndrome; PE: pulmonary 
embolism. 
Overall mortality due to VTE events was 21.1% (95% CI: 13.6-30.4). 
Discussion 
The TREVO study included elective and urgent surgical patients from eight specialties. 
The incidence of VTE (as indicated by in-hospital outcome) was estimated at 1.33/1000 
admissions. This figure is extremely low compared to the risk attributed to the 
Portuguese surgical population in the ENDORSE study (69%).
6,10
 However, the latter 
assessed risk factors rather than outcome and only in acute patients undergoing general 
surgery or urogynecological or ortho trauma surgery, which carry a higher risk of VTE. 
Bilimoria et al. reported a risk of 5.35/1000 in a multicenter study in the US assessing 
outcomes in patients undergoing orthopedic, neurological, cardiothoracic, urological 
and general surgery.
8
 The authors highlight the fact that surveillance bias is a major 
factor influencing results, especially when local protocols are more interventionist in 
requesting imaging exams. Some events may have only mild symptoms that are 
disregarded in centers where standard diagnostic imaging is guided by symptoms, while 
in others, such as trauma centers, imaging studies are performed as routine.
8
 
The incidence of VTE in this study reflects our institutional protocol for 
thromboprophylaxis, which decreases the incidence of VTE by 50-75%.
9
 In addition, 
symptomatic VTE, the outcome considered, accounts for only around 50% of all VTE 
events.
3
 Even so, the TREVO study shows lower rates than reported in the literature, 
which may be related to exclusion of cases for inconsistencies in medical records or less 
precise diagnosis and/or recording. The latter would explain the high mortality, since 
recording of fatal events is necessarily stricter; the literature shows a lower incidence of 
PE than of other VTE, unlike in our study, which raises the possibility that VTE other 
than PE was underdiagnosed. On the other hand, the lower incidence may reflect more 
effective thromboprophylaxis. 
In the TREVO study, the specialty with the highest risk of VTE was neurosurgery, 
while in the literature
4,10–13
 it is orthopedic surgery. In a retrospective study of 94 cases 
of in-hospital VTE, Wang et al. identified cranial surgery as an independent predictor of 
VTE, with a particularly high odds ratio of 16.1.
9
 In an earlier study, Hamilton et al. 
observed that half of neurosurgical patients presented detectable VTE on screening, 
while only 5% developed symptomatic VTE.
14
 A known risk factor for VTE that may 
account for this finding is the fact that cranial surgery entails central venous 
catheterization in a high proportion of cases, and a retrospective study found that central 
venous catheterization doubled the risk of in-hospital VTE.
15
 Furthermore, many of 
these patients are hospitalized in intensive care units and have longer operating times 
and hospital stays, which are additional risk factors for VTE. Limitations on the use of 
pharmacological thrombophylaxis in neurosurgery, irrespective of patient 
characteristics, may also help explain the increased risk observed. This further 
highlights the need, already stated in some guidelines,
4,5
 for mechanical 
thromboprophylaxis beginning in the preoperative period in neurosurgical patients as 
well as pharmacological thromboprophylaxis in those at increased risk of VTE. 
The aim of the TREVO study was to estimate the risk of in-hospital VTE. While the 
high risk of VTE in major orthopedic surgery is well known, symptomatic postoperative 
event rates up to discharge do not reflect overall risk, since mean time to symptomatic 
events is 17 days in the case of hip arthroplasty and seven days in the case of knee 
arthroplasty, the high-risk period extending to 12 weeks for the former and six weeks 
for the latter.
1,13
 With enhanced recovery programs becoming increasingly common, 
such patients are now discharged long before the periods referred to above, which 
introduces even more bias into recorded in-hospital events as a measure of risk and may 
explain why orthopedic surgery occupied fifth place (1.09/1000 episodes) in the 
TREVO study. 
The risk associated with urological procedures (1.55/1000) was the second highest in 
our study. Although risk in this patient group has been less studied, a recent cohort 
study reported moderate to high VTE event rates for total (3.96%) and partial 
cystectomy (2.35%), followed by radical open nephrectomy (1.67%).
16
 Other studies 
have reported a high risk of VTE in renal transplant recipients (7.9-9.1%).
17,18
 The 
TREVO study population included patients in a renal transplantation unit, which would 
have contributed to the high values observed. Beyer et al. reported a high incidence of 
PE (5.8%) in prostatectomy,
19
 another common procedure in the population studied. 
The year-on-year trend for declining overall VTE rates between 2008 and 2012 supports 
the hypothesis of progressively more effective thromboprophylaxis. 
Overall mortality due to VTE events (21.1%) was higher than reported in the literature 
and close to mortality due to PE (22.0%), which was also high. Reis reports early VTE 
mortality of 12.6%.
2
Data from the Nationwide Inpatient Sample in the US indicate in-
hospital mortality from PE of 12.3% to 8.2%, with a falling trend over the years.
20
 A 
Norwegian study reported 30-day mortality of 9.7% from PE and 4.6% from 
DVT.
21
 Comparison of the mortality observed in the TREVO study with the above 
findings supports the idea that non-fatal events are underdiagnosed. 
Neuraxial anesthesia was used in 12.2% of procedures in this study. In a meta-analysis, 
Rodgers et al. showed that epidural anesthesia dramatically reduces risk for VTE, by 
44% for DVT and by 55% for PE.
22
 Another meta-analysis confirmed the benefit of 
continuous lumbar epidural anesthesia in the postoperative period to reduce the risk of 
VTE following lower-limb surgery or prostatectomy.
23
 This may help explain the lower 
risk found in orthopedic procedures, since neuraxial anesthesia is the most commonly 
used technique in major lower-limb surgery. 
With regard to ASA physical status, most of the study population (55.1%) was 
classified as ASA III. The literature reports a worsening of VTE risk in hip arthroplasty 
with progressively higher ASA classification.
24
 
The study has certain limitations. Firstly, it was retrospective and therefore 
observational and dependent on the information available in medical records. Secondly, 
cases were excluded for inconsistencies in medical records. Thirdly, there may also 
have been surveillance bias between departments, which, together with the second 
limitation, may have contributed to underdiagnosis. Fourthly, it analyzed in-hospital 
events only, disregarding those that occurred after discharge. Lastly, data on 
thromboembolic prophylaxis was not available in all cases, particularly preoperative 
assessment of VTE risk (and indication for prophylaxis in light of the latest evidence) in 
order to more accurately assess the impact of thromboprophylaxis. 
On the positive side, the TREVO study is, as far as we know, the only study on 
postoperative venous thromboembolism in Portugal apart from the ENDORSE study, 
which had a much smaller sample; TREVO included 67635 patients, with 90 
documented cases of VTE, which is comparable to other international studies. The 
study was based on outcomes rather than assessment of risk, and care was taken to 
avoid selection bias, through use of ICD codes and the VTE criteria defined by the Joint 
Commission International. 
Conclusion 
In this study, the incidence of symptomatic postoperative VTE was 1.33/1000 
admissions. Neurosurgery showed the greatest risk for VTE and PE. 
Mortality was 21.1%. Underdiagnosis cannot be excluded, nor can failure to record non-
fatal events. 
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